Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/37/98/ce/3798ceb7-fe20-c844-6781-d1419fba380d/mza_76859653136935102.jpg/600x600bb.jpg

Heart Matters

ReachMD

193 episodes

3 weeks ago

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more. So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.

Science

Medicine

RSS

All content for Heart Matters is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

Heart Matters

2 years ago

Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Javed Butler, MD

There’s no approved therapies specifically targeting obesity and HFpEF, but based on the STEP-HFpEF study that was presented at the 2023 ESC Congress, the treatment option semaglutide improves heart failure-related symptoms, physical function, and weight loss among patients with HFpEF and obesity. Here to walk through the study’s key findings with Dr. Mary Katherine Cheeley is fellow ReachMD host, Dr. Javed Butler, President of Baylor Scott and White Research Institute in Dallas, Texas.